12 Jun 2015
Mumbai: In the first effort to regulate an industry that covers everything from thermometers to prostheses, the government plans to set up a regulator to oversee country's USD 4 billion medical device industry.
23 Jul 2015
New Delhi: Drug major Lupin today said it is acquiring US-based Gavis for USD 880 million (over Rs 5,610 crore) to consolidate presence in the world's largest pharmaceuticals market.
06 Jun 2015
New Delhi: Competition Commission of India (CCI) has slapped a penalty of Rs 64 crore on drugmakers GlaxoSmithKline Pharmaceuticals and Sanofi for collusive bidding in supply of a meningitis vaccine to the government for Haj pilgrims.
21 Mar 2015
Washington: US anti-trust regulator FTC has passed its final order settling charges that Sun Pharma's USD 4 billion deal to acquire Ranbaxy Laboratories could result in unfair business practices.
10 Dec 2014
New Delhi: Drug major Cipla on Wednesday said its Mauritius subsidiary Meditab Holdings has signed a deal to sell its entire 48.22 percent stake in China-based Jiangsu Cdymax Pharmaceuticals for USD 18.5 million (over Rs 114 crore).
07 Apr 2015
New Delhi: Glenmark Pharmaceuticals on Tuesday said it has received the final approval from the United States Food and Drug Administration (USFDA) for sale of drugs meant to prevent post-menopause osteoporosis.
07 Jan 2015
Washington: A new study suggests that apart from urine, pharmaceuticals and chemicals from personal care products end up in swimming pools and may impact your health. These chemicals interact with chlorine to produce disinfection byproducts with unknown properties.
13 Mar 2015
New Delhi: Private sector lender HDFC Bank on Friday denied any linkages with individuals arrested by the CBI for allegedly leaking official government documents and said that the charges against it were "baseless and untrue".
31 Dec 2014
New Delhi: Glenmark Pharmaceuticals has received shareholders' nod to raise up to USD 300 million (around Rs 1,890 crore) through issue of securities.
26 Feb 2015
New Delhi: Glenmark Pharmaceuticals on Thursday announced receipt of approval from the US health regulator to sell its generic version of AbbVie Inc's blood pressure drug Tarka in the American market.